Learn what aficamten is, how this next‑generation cardiac myosin inhibitor works in hypertrophic cardiomyopathy (HCM), and why its targeted, tunable mechanism is reshaping treatment options for obstructive HCM.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs